Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This month tags : N::A symbols : Jnj save search
Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsight
Published: 2024-04-24 (Crawled : 22:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
OTLK | News P | $8.2 0.0% 240K
|
Health Technology
| Email alert
Add to watchlist
KOD | News | $3.37 1.2% 1.19% 340K
|
Health Technology
| Email alert
Add to watchlist
OPT | News | $3.46 2.98% 2.89% 8.2K
|
Health Technology
| Email alert
Add to watchlist
disease market
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Published: 2024-04-24 (Crawled : 21:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
NBTX | $5.71 1.04% 1.4K
|
Manufacturing
| Email alert
Add to watchlist
business year update financial results
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
CDTX | News | $11.94 16.49% 14.15% 170K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
cd388 million global commercial therapeutics development
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Published: 2024-04-24 (Crawled : 08:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K
|
n/a
|
| O: 2.16%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
avt05 simponi biosimilar for topline results study
Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors
Published: 2024-04-24 (Crawled : 07:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
precision company million series therapeutics
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
first ceo revenue medical
Top Biopharma Brands Reach Audiences 10x More Qualified with Veeva Crossix Prime Segments
Published: 2024-04-23 (Crawled : 11:00) - prnewswire.com
VEEV | $200.52 -0.29% -0.26% 540K
|
Technology Services
|
| O: 1.02%
H: 2.26%
C: 0.12%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
brands reach biopharma prime
Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsight
Published: 2024-04-22 (Crawled : 22:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
OTLK | News P | $8.2 0.0% 240K
|
Health Technology
|
| O: 1.48%
H: 2.8%
C: -0.12%
OPT | News | $3.46 2.98% 2.89% 8.2K
|
Health Technology
|
| O: 3.25%
H: 0.0%
C: -3.72%
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
|
| O: 0.79%
H: 0.59%
C: -2.34%
KOD | News | $3.37 1.2% 1.19% 340K
|
Health Technology
|
| O: 0.29%
H: 3.79%
C: -2.92%
EYPT | News | $16.47 -6.26% -6.68% 1.1M
|
Health Technology
|
| O: 7.73%
H: 2.3%
C: -3.78%
CLSD | News P | $1.33 -2.92% -3.01% 200K
|
Health Technology
|
| O: 1.42%
H: 3.5%
C: -4.2%
ADVM | News | $10.19 -7.36% -7.95% 310K
|
Health Technology
|
| O: -0.26%
H: 4.95%
C: -2.74%
macular growth market
ArriVent Appoints Kristine Peterson to its Board of Directors
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
White River Bancshares Co. Earns $509,000, or $0.51 Per Diluted Share, in First Quarter 2024; Highlighted by Higher Net Interest Income and Double Digit Loan and Deposit Growth Year-Over-Year
Published: 2024-04-19 (Crawled : 13:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
SBNY | News | $3.5 0.0% 250K
|
Finance
|
| O: 4.55%
H: 4.06%
C: 4.06%
first growth
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
RPRX | $27.98 0.58% 0.57% 1.8M
|
Health Technology
|
| O: 1.07%
H: 1.22%
C: 1.11%
first pharma royalty financial results
Compass Diversified-Backed The Honey Pot Co. Strengthens Its Board With The Appointment of Three New Directors
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
CODI | $23.22 0.04% 0.0% 130K
|
Finance
|
| O: 0.36%
H: 0.0%
C: 0.0%
pot honey
Health eCareers and AAPPR Expand Partnership to Advance Physician and Provider Recruitment and DE&I Efforts
Published: 2024-04-17 (Crawled : 21:00) - j2global.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
partnership health
Royalty Pharma Declares Second Quarter 2024 Dividend
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
RPRX | $27.98 0.58% 0.57% 1.8M
|
Health Technology
|
| O: -1.5%
H: 0.84%
C: 0.25%
pharma royalty
Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published: 2024-04-17 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
treatment global growth market
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
stelara fda biosimilar approval teva
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
RXRX | $7.94 3.12% 3.02% 7.1M
|
Professional, Scientific, and T...
|
| O: -9.4%
H: 2.1%
C: -0.53%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
commercial
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
GNMSF | News | $290.34 3.83% 340
|
Health Technology
|
| O: 4.94%
H: 0.0%
C: -3.66%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: -1.29%
H: 1.91%
C: 1.27%
darzalex sales first for
Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC Announce a $78 Million Class Action Settlement for Third Party Payors That Paid or Reimbursed Costs for Prescription Opioids or Treatment Related to Opioid Misuse, Addiction, and/or Overdose
Published: 2024-04-15 (Crawled : 20:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
opioid million treatment for
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -1.73%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
research global gastrointestinal therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.